Filing Details
- Accession Number:
- 0001181431-14-033367
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-10-02 17:58:47
- Reporting Period:
- 2014-09-30
- Filing Date:
- 2014-10-02
- Accepted Time:
- 2014-10-02 17:58:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1492426 | Horizon Pharma Plc | HZNP | Pharmaceutical Preparations (2834) | 272179987 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1240116 | J Robert Vaere De | C/O Horizon Pharma Plc Adelaide Chambers, Peter Street Dublin, Ireland L2 8 | Evp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2014-09-30 | 112,166 | $0.00 | 206,456 | No | 4 | A | Direct | |
Ordinary Shares | Disposition | 2014-09-30 | 51,942 | $12.28 | 154,514 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Footnotes
- Fully vested restricted stock units issued on the Separation Date as defined in that certain Executive Employment and Transition Agreement dated June 17, 2014.
- Includes 23,467 shares of the Company's ordinary shares acquired pursuant to an employee stock purchase program.
- Reflects restricted stock units surrendered via a net settlement to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit.